Astrocytoma other diagnostic studies: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 11: Line 11:
* For lesions with areas of contrast enhancement the specimen should be obtained from those areas.
* For lesions with areas of contrast enhancement the specimen should be obtained from those areas.
* For lesions with no intra-tumor enhancement the specimen should be obtained from the center of the tumor.
* For lesions with no intra-tumor enhancement the specimen should be obtained from the center of the tumor.
Findings suggestive of/diagnostic of astrocytoma include:
Pathological findings diagnostic of astrocytoma include:
*On microscopic histopathological analysis, characteristic findings of astrocytoma is:<ref name=":0">{{cite book | last = Mattle | first = Heinrich | title = Fundamentals of neurology : an illustrated guide | publisher = Thieme | location = Stuttgart New York | year = 2017 | isbn = 9783131364524 }}</ref>
*On microscopic histopathological analysis, characteristic findings of astrocytoma is:<ref name=":0">{{cite book | last = Mattle | first = Heinrich | title = Fundamentals of neurology : an illustrated guide | publisher = Thieme | location = Stuttgart New York | year = 2017 | isbn = 9783131364524 }}</ref>
**Grade 1: Cells appearance is normal and growth rate is slow.
**Grade 1: Cells appearance is normal and growth rate is slow.
**Grade 2: There might be some atypical cells inside tumor. Mitosis rate is relatively slow.
**Grade 2: There might be some atypical cells inside tumor. Mitosis rate is relatively slow.
**Grade 3 and 4: Tumor cells are anaplastic and malignant with high mitosis rate.
**Grade 3 and 4: Tumor cells are anaplastic and malignant with high mitosis rate.
Molecular findings diagnostic of astrocytoma include:
{{Family tree/start}}
{{Family tree |boxstyle=text-align: left; | | | | | | | | | | | | | | | A01 | | | | | | | | | | | |A01=• Stem cell<br>• Precursor cell<br>• Glial cell<br> }}
{{Family tree | | | | | | | |,|-|-|-|-|-|-|-|+|-|-|-|-|-|-|-|.| | | | | }}
{{Family tree | | | | | | | B01 | | | | | | B02 | | | | | | B03 | | | | B01=IDH1 mutation|B02=• 10q loss<br>• PTEN mutation<br>• EGFR overexpression<br>• MDM2 overexpression<br>|B03=• KIAA1549-BRAF fusion<br>• MAPK/ERK abnormalities<br>}}
{{Family tree | | | | | | | |!| | | | | | | |!| | | | | | | |!| | | | | }}
{{Family tree | | | | | | | C01 | | | | | | C02 | | | | | | C03 | | | | C01=• p53 mutation<br>• PDGF/PDGFRA overexpression<br>|C02=Primary glioblastoma
grade IV|C03=Pilocytic astrocytoma grade I}}
{{Family tree | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | }}
{{Family tree | | | | | | | D01 | | | | | | | | | | | | | | | | | | | | D01=Diffuse astrocytoma grade II}}
{{Family tree | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | }}
{{Family tree | | | | | | | E01 | | | | | | | | | | | | | | | | | | | | E01=Chr 19q loss}}
{{Family tree | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | }}
{{Family tree | | | | | | | F01 | | | | | | | | | | | | | | | | | | | | F01=Anaplastic astocytoma grade III}}
{{Family tree | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | }}
{{Family tree | | | | | | | G01 | | | | | | | | | | | | | | | | | | | | G01=10q loss}}
{{Family tree | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | }}
{{Family tree | | | | | | | H01 | | | | | | | | | | | | | | | | | | | | H01=Glioblastoma (secondary) grade IV}}
{{Family tree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | }}
{{Family tree/end}}


==References==
==References==

Revision as of 18:31, 4 January 2019

Astrocytoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Astrocytoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-Ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Study

Case #1

Astrocytoma other diagnostic studies On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Astrocytoma other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Astrocytoma other diagnostic studies

CDC on Astrocytoma other diagnostic studies

Astrocytoma other diagnostic studies in the news

Blogs on Astrocytoma other diagnostic studies

Directions to Hospitals Treating Astrocytoma

Risk calculators and risk factors for Astrocytoma other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.

Overview

Other Diagnostic Studies

Biopsy is helpful in the diagnosis of astrocytomas:

  • Astrocytomas are histologically heterogenous
  • Obtaining small specimen from astrocytomas might lead to false diagnosis.
  • For lesions with areas of contrast enhancement the specimen should be obtained from those areas.
  • For lesions with no intra-tumor enhancement the specimen should be obtained from the center of the tumor.

Pathological findings diagnostic of astrocytoma include:

  • On microscopic histopathological analysis, characteristic findings of astrocytoma is:[1]
    • Grade 1: Cells appearance is normal and growth rate is slow.
    • Grade 2: There might be some atypical cells inside tumor. Mitosis rate is relatively slow.
    • Grade 3 and 4: Tumor cells are anaplastic and malignant with high mitosis rate.

Molecular findings diagnostic of astrocytoma include:

 
 
 
 
 
 
 
 
 
 
 
 
 
 
• Stem cell
• Precursor cell
• Glial cell
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IDH1 mutation
 
 
 
 
 
• 10q loss
• PTEN mutation
• EGFR overexpression
• MDM2 overexpression
 
 
 
 
 
• KIAA1549-BRAF fusion
• MAPK/ERK abnormalities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
• p53 mutation
• PDGF/PDGFRA overexpression
 
 
 
 
 
Primary glioblastoma grade IV
 
 
 
 
 
Pilocytic astrocytoma grade I
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Diffuse astrocytoma grade II
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chr 19q loss
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Anaplastic astocytoma grade III
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10q loss
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Glioblastoma (secondary) grade IV
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

References

  1. Mattle, Heinrich (2017). Fundamentals of neurology : an illustrated guide. Stuttgart New York: Thieme. ISBN 9783131364524.

Template:WH Template:WS